Family Capital Trust’s Bristol-Myers Squibb BMY Stock Holding History

Family Capital Trust’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-3,000	Closed	-$167K	–	58
2017 Q2	$167K	Hold	3,000	–	–	0.09%	40
2017 Q1	$168K	Hold	3,000	–	–	0.09%	40
2016 Q4	$175K	Hold	3,000	–	–	0.1%	43
2016 Q3	$162K	Hold	3,000	–	–	0.09%	43
2016 Q2	$221K	Hold	3,000	–	–	0.13%	39
2016 Q1	$192K	Hold	3,000	–	–	0.11%	42
2015 Q4	$206K	Hold	3,000	–	–	0.11%	40
2015 Q3	$178K	Sell	3,000 -190	-6%	-$12.1K	0.1%	46
2015 Q2	$212K	Buy	3,190 +190	+6%	+$12.5K	0.12%	42
2015 Q1	$194K	Hold	3,000	–	–	0.11%	48
2014 Q4	$177K	Hold	3,000	–	–	0.09%	55
2014 Q3	$154K	Hold	3,000	–	–	0.08%	57
2014 Q2	$146K	Hold	3,000	–	–	0.08%	60
2014 Q1	$156K	Hold	3,000	–	–	0.08%	58
2013 Q4	$159K	Hold	3,000	–	–	0.09%	56
2013 Q3	$139K	Hold	3,000	–	–	0.08%	65
2013 Q2	$134K	Buy	+3,000	New	+$130K	0.09%	65

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Family Capital Trust's BMY Position: Q3 2017 in Review

Family Capital Trust sold out of Bristol-Myers Squibb (BMY) in Q3 2017, closing a stake of 3,000 shares — an estimated $167K sold.

Family Capital Trust first reported a position in BMY in Q2 2013 and held it in 17 quarters. The position peaked at $221K in Q2 2016. 1,641 funds tracked by Wall St. Rank hold BMY as of Q3 2017.

Family Capital Trust reported no remaining Bristol-Myers Squibb position as of Q3 2017 after selling out during the quarter.
Family Capital Trust sold 3,000 Bristol-Myers Squibb shares in Q3 2017, an estimated $167K.
Family Capital Trust first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 17 quarters.
Family Capital Trust's Bristol-Myers Squibb position peaked at $221K in Q2 2016.
1,641 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2017.

Based on Family Capital Trust's 13F filing for Q3 2017, filed 17 Oct 2017.